Fitzgerald, Sandra
Blenkiron, Cherie
Stephens, Rosalie
Mathy, Jon A.
Somers-Edgar, Tiffany
Rolfe, Gill
Martin, Richard
Jackson, Christopher
Eccles, Michael
Robb, Tamsin
Rodger, Euan
Lawrence, Ben
Guilford, Parry
Lasham, Annette
Print, Cristin G. http://orcid.org/0000-0001-8345-7812
Funding for this research was provided by:
Healthier Lives National Science Challenge, NZ
Cancer Research Trust, NZ
Maurice Wilkins Centre for Molecular Biodiscovery
William Staunton Scholarship Fund
University of Auckland School of Medicine Foundation
University of Auckland
Article History
Accepted: 4 April 2023
First Online: 26 April 2023
Declarations
:
: Open Access funding enabled and organized by CAUL and its Member Institutions. This work was financially supported by the Healthier Lives National Science Challenge, Cancer Research Trust NZ, the William Staunton Scholarship Fund, the Maurice Wilkins Centre and the University of Auckland School of Medicine Foundation.
: The authors have no conflicts of interest that are directly relevant to this article.
: This study was approved by the NZ Health and Disability Ethics Committee, ethical approval number 16/NTA/180.
: All patients provided written informed consent.
: Not applicable.
: The data that support the findings of this study are available upon reasonable request from the corresponding author.
: Not applicable.
: CGP, PG, RS, JM and CB initiated the study and contributed to the conception and design. SF contributed to the design of the study, developed molecular protocols, analysis of samples and data, and along with CGP was the primary author of this publication. AL provided research supervision. TS, RS, JM, RM, CJ, BL and GR contributed to the clinical protocol design, patient recruitment, clinical and genomic data collection as well as overall interpretation. TR contributed to statistical analysis. ER contributed to the sequencing panel design. All authors contributed to the revision and approved the final manuscript.